Share Price and Basic Stock Data
Last Updated: December 19, 2025, 8:40 pm
| PEG Ratio | -20.27 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Gujarat Fluorochemicals Ltd operates within the specialty chemicals sector, a domain characterized by its niche products and growing demand. The company reported a market capitalization of ₹36,447 Cr, with its share price standing at ₹3,318. Over the past fiscal years, revenue has shown a significant upward trajectory, peaking at ₹5,685 Cr in FY 2023 before declining to ₹4,281 Cr in FY 2024. This downturn raises questions about demand fluctuations and market dynamics. However, the trailing twelve months (TTM) revenue indicates a rebound to ₹4,842 Cr. Quarterly sales figures reflect a similar pattern, with a notable drop in Q2 FY 2024, where sales fell to ₹947 Cr, before gradually recovering in subsequent quarters. Such fluctuations suggest the company is navigating a volatile market, typical for specialty chemicals, but the overall trend remains positive.
Profitability and Efficiency Metrics
Profitability metrics for Gujarat Fluorochemicals reveal a mixed performance. The operating profit margin (OPM) was robust at 27%, indicating efficiency in managing operational costs. However, the OPM has seen a decline from 36% in Mar 2023 to 21% in Mar 2024, suggesting increased pressure on margins possibly due to rising input costs or competitive pricing strategies. The net profit for FY 2024 stood at ₹435 Cr, down from ₹1,323 Cr in FY 2023, which is a significant drop that underscores the challenges faced by the company. The return on equity (ROE) at 8.29% and return on capital employed (ROCE) at 9.89% indicate a reasonable, albeit not exceptional, efficiency in generating returns for shareholders. The interest coverage ratio (ICR) of 8.27x suggests a comfortable ability to meet interest obligations, reflecting a solid operational footing despite profitability pressures.
Balance Sheet Strength and Financial Ratios
The balance sheet of Gujarat Fluorochemicals appears well-structured, with total borrowings reported at ₹1,722 Cr against reserves of ₹7,606 Cr. This indicates a strong equity base, with a debt-to-equity ratio of 0.27, suggesting a conservative approach to leveraging. The company’s current ratio of 1.70 implies a healthy liquidity position, capable of meeting short-term obligations. However, the cash conversion cycle (CCC) has extended to 418 days, signaling potential inefficiencies in inventory management or receivables collection, which could strain cash flows. Additionally, the price-to-book value (P/BV) ratio of 6.10x indicates that the stock may be trading at a premium relative to its book value, which could deter value-focused investors. Overall, while the balance sheet shows strength, the efficiency ratios warrant close attention.
Shareholding Pattern and Investor Confidence
The shareholding structure of Gujarat Fluorochemicals reflects a stable yet evolving landscape. Promoters hold a significant 61.39% stake, providing a reassuring signal of commitment and control. However, foreign institutional investors (FIIs) have reduced their stake to 4.36%, while domestic institutional investors (DIIs) have increased their holdings to 12.73%. This shift could indicate a growing confidence among domestic investors amid the company’s recent challenges. The public shareholding stands at 21.51%, which has seen a gradual decline, suggesting a consolidation of ownership. With 66,493 shareholders, the company maintains a broad base of retail investors, which is critical for liquidity. The trends in shareholding could play a role in influencing market perceptions and investor sentiment moving forward.
Outlook, Risks, and Final Insight
Looking ahead, Gujarat Fluorochemicals faces a landscape filled with both opportunities and challenges. The specialty chemicals sector is poised for growth, driven by increasing demand across various industries, including automotive and electronics. However, the company must navigate risks such as fluctuating raw material prices and potential regulatory changes that could impact profitability. Additionally, the declining margins and increasing cash conversion cycle present operational challenges that need addressing. Investors should weigh these factors carefully. A focus on improving operational efficiency and maintaining strong liquidity could enhance the company’s resilience. Ultimately, while the stock may present growth potential due to its established market position, the current financial dynamics suggest that cautious optimism is warranted for prospective investors.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 394 Cr. | 42.9 | 83.5/41.2 | 24.5 | 20.5 | 0.93 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 29.2 Cr. | 59.5 | 93.8/56.0 | 14.0 | 89.6 | 1.68 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 49.6 Cr. | 729 | 953/600 | 22.8 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,399 Cr. | 75.0 | 111/74.1 | 22.5 | 22.0 | 0.67 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 643 Cr. | 258 | 404/241 | 23.1 | 93.8 | 0.97 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,811.84 Cr | 727.68 | 74.82 | 183.02 | 0.45% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,334 | 1,461 | 1,418 | 1,471 | 1,209 | 947 | 992 | 1,133 | 1,176 | 1,188 | 1,148 | 1,225 | 1,281 |
| Expenses | 875 | 926 | 895 | 942 | 861 | 783 | 786 | 895 | 914 | 893 | 854 | 919 | 937 |
| Operating Profit | 459 | 536 | 523 | 529 | 348 | 164 | 206 | 238 | 262 | 295 | 294 | 306 | 344 |
| OPM % | 34% | 37% | 37% | 36% | 29% | 17% | 21% | 21% | 22% | 25% | 26% | 25% | 27% |
| Other Income | 26 | 24 | 21 | 19 | 15 | 13 | 13 | 18 | 9 | 9 | 14 | 26 | 23 |
| Interest | 21 | 23 | 38 | 35 | 28 | 34 | 37 | 34 | 37 | 42 | 42 | 26 | 30 |
| Depreciation | 55 | 57 | 60 | 64 | 66 | 68 | 72 | 81 | 85 | 90 | 91 | 89 | 90 |
| Profit before tax | 409 | 480 | 446 | 449 | 269 | 75 | 110 | 141 | 149 | 172 | 175 | 217 | 247 |
| Tax % | 26% | 26% | 26% | 26% | 25% | 29% | 27% | 28% | 28% | 30% | 28% | 12% | 26% |
| Net Profit | 303 | 357 | 331 | 332 | 201 | 53 | 80 | 101 | 108 | 121 | 126 | 191 | 184 |
| EPS in Rs | 27.88 | 32.88 | 29.99 | 30.21 | 18.30 | 4.82 | 7.28 | 9.19 | 9.83 | 11.02 | 11.47 | 17.39 | 16.75 |
Last Updated: August 20, 2025, 10:00 am
Below is a detailed analysis of the quarterly data for Gujarat Fluorochemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 1,281.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,225.00 Cr. (Mar 2025) to 1,281.00 Cr., marking an increase of 56.00 Cr..
- For Expenses, as of Jun 2025, the value is 937.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 919.00 Cr. (Mar 2025) to 937.00 Cr., marking an increase of 18.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 344.00 Cr.. The value appears strong and on an upward trend. It has increased from 306.00 Cr. (Mar 2025) to 344.00 Cr., marking an increase of 38.00 Cr..
- For OPM %, as of Jun 2025, the value is 27.00%. The value appears strong and on an upward trend. It has increased from 25.00% (Mar 2025) to 27.00%, marking an increase of 2.00%.
- For Other Income, as of Jun 2025, the value is 23.00 Cr.. The value appears to be declining and may need further review. It has decreased from 26.00 Cr. (Mar 2025) to 23.00 Cr., marking a decrease of 3.00 Cr..
- For Interest, as of Jun 2025, the value is 30.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 26.00 Cr. (Mar 2025) to 30.00 Cr., marking an increase of 4.00 Cr..
- For Depreciation, as of Jun 2025, the value is 90.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 89.00 Cr. (Mar 2025) to 90.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 247.00 Cr.. The value appears strong and on an upward trend. It has increased from 217.00 Cr. (Mar 2025) to 247.00 Cr., marking an increase of 30.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 12.00% (Mar 2025) to 26.00%, marking an increase of 14.00%.
- For Net Profit, as of Jun 2025, the value is 184.00 Cr.. The value appears to be declining and may need further review. It has decreased from 191.00 Cr. (Mar 2025) to 184.00 Cr., marking a decrease of 7.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 16.75. The value appears to be declining and may need further review. It has decreased from 17.39 (Mar 2025) to 16.75, marking a decrease of 0.64.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:17 am
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,851 | 2,729 | 2,606 | 2,650 | 3,954 | 5,685 | 4,281 | 4,737 | 4,864 |
| Expenses | 3,105 | 1,941 | 2,167 | 2,052 | 2,785 | 3,719 | 3,366 | 3,638 | 3,556 |
| Operating Profit | 745 | 788 | 439 | 598 | 1,168 | 1,965 | 915 | 1,100 | 1,308 |
| OPM % | 19% | 29% | 17% | 23% | 30% | 35% | 21% | 23% | 27% |
| Other Income | 112 | 78 | 190 | 199 | 161 | 172 | 100 | 115 | 69 |
| Interest | 279 | 56 | 105 | 113 | 78 | 117 | 133 | 147 | 131 |
| Depreciation | 299 | 164 | 192 | 202 | 205 | 236 | 286 | 355 | 361 |
| Profit before tax | 279 | 645 | 332 | 482 | 1,045 | 1,785 | 595 | 713 | 885 |
| Tax % | 14% | -93% | 43% | 146% | 26% | 26% | 27% | 23% | |
| Net Profit | 240 | 1,246 | 189 | -222 | 776 | 1,323 | 435 | 546 | 680 |
| EPS in Rs | 17.87 | -19.91 | 71.66 | 120.97 | 39.59 | 49.71 | 61.90 | ||
| Dividend Payout % | 15% | 0% | 0% | 0% | 6% | 3% | 8% | 6% |
YoY Net Profit Growth
| Year | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 419.17% | -84.83% | -217.46% | 449.55% | 70.49% | -67.12% | 25.52% |
| Change in YoY Net Profit Growth (%) | 0.00% | -504.00% | -132.63% | 667.01% | -379.06% | -137.61% | 92.64% |
Gujarat Fluorochemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 7 years from 2018-2019 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 13% |
| 3 Years: | 6% |
| TTM: | 14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 21% |
| 3 Years: | -11% |
| TTM: | 82% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 45% |
| 3 Years: | 0% |
| 1 Year: | -4% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 12% |
| 3 Years: | 13% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 5:35 am
Balance Sheet
Last Updated: December 4, 2025, 1:20 am
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 4,756 | 3,499 | 3,705 | 3,482 | 4,244 | 5,510 | 5,925 | 7,242 | 7,606 |
| Borrowings | 2,000 | 968 | 1,718 | 1,581 | 1,556 | 1,515 | 2,096 | 2,080 | 1,722 |
| Other Liabilities | 2,986 | 441 | 634 | 895 | 1,067 | 1,335 | 1,201 | 1,270 | 1,279 |
| Total Liabilities | 9,753 | 4,919 | 6,067 | 5,969 | 6,878 | 8,371 | 9,233 | 10,602 | 10,618 |
| Fixed Assets | 3,813 | 2,305 | 2,414 | 2,367 | 2,514 | 3,111 | 4,264 | 4,285 | 4,263 |
| CWIP | 724 | 229 | 318 | 400 | 680 | 1,158 | 1,128 | 1,568 | 1,806 |
| Investments | 524 | 342 | 259 | 88 | 20 | 1 | 1 | 289 | 56 |
| Other Assets | 4,691 | 2,042 | 3,076 | 3,114 | 3,665 | 4,101 | 3,840 | 4,460 | 4,493 |
| Total Assets | 9,753 | 4,919 | 6,067 | 5,969 | 6,878 | 8,371 | 9,233 | 10,602 | 10,618 |
Below is a detailed analysis of the balance sheet data for Gujarat Fluorochemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 11.00 Cr..
- For Reserves, as of Sep 2025, the value is 7,606.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,242.00 Cr. (Mar 2025) to 7,606.00 Cr., marking an increase of 364.00 Cr..
- For Borrowings, as of Sep 2025, the value is 1,722.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 2,080.00 Cr. (Mar 2025) to 1,722.00 Cr., marking a decrease of 358.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1,279.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,270.00 Cr. (Mar 2025) to 1,279.00 Cr., marking an increase of 9.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 10,618.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 10,602.00 Cr. (Mar 2025) to 10,618.00 Cr., marking an increase of 16.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 4,263.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,285.00 Cr. (Mar 2025) to 4,263.00 Cr., marking a decrease of 22.00 Cr..
- For CWIP, as of Sep 2025, the value is 1,806.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,568.00 Cr. (Mar 2025) to 1,806.00 Cr., marking an increase of 238.00 Cr..
- For Investments, as of Sep 2025, the value is 56.00 Cr.. The value appears to be declining and may need further review. It has decreased from 289.00 Cr. (Mar 2025) to 56.00 Cr., marking a decrease of 233.00 Cr..
- For Other Assets, as of Sep 2025, the value is 4,493.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,460.00 Cr. (Mar 2025) to 4,493.00 Cr., marking an increase of 33.00 Cr..
- For Total Assets, as of Sep 2025, the value is 10,618.00 Cr.. The value appears strong and on an upward trend. It has increased from 10,602.00 Cr. (Mar 2025) to 10,618.00 Cr., marking an increase of 16.00 Cr..
Notably, the Reserves (7,606.00 Cr.) exceed the Borrowings (1,722.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 743.00 | -180.00 | 438.00 | 597.00 | 0.00 | 0.00 | 913.00 | -1.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 184 | 77 | 79 | 92 | 72 | 71 | 72 | 92 |
| Inventory Days | 736 | 351 | 390 | 404 | 314 | 375 | 435 | 487 |
| Days Payable | 471 | 127 | 176 | 159 | 170 | 174 | 144 | 162 |
| Cash Conversion Cycle | 449 | 301 | 293 | 338 | 216 | 272 | 363 | 418 |
| Working Capital Days | 67 | 22 | -0 | 6 | 33 | 62 | 60 | 97 |
| ROCE % | 11% | 9% | 11% | 20% | 30% | 10% | 10% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| HDFC Mid Cap Fund | 1,386,604 | 0.52 | 474.7 | N/A | N/A | N/A |
| Motilal Oswal Large and Midcap Fund | 1,079,452 | 2.44 | 369.55 | 1,028,275 | 2025-12-15 05:01:00 | 4.98% |
| DSP Mid Cap Fund | 607,640 | 1.05 | 208.03 | N/A | N/A | N/A |
| Nippon India Growth Mid Cap Fund | 605,000 | 0.49 | 207.12 | N/A | N/A | N/A |
| Mirae Asset Focused Fund | 588,038 | 2.55 | 201.31 | 556,129 | 2025-12-15 05:01:00 | 5.74% |
| DSP Flexi Cap Fund | 536,826 | 1.49 | 183.78 | 762,208 | 2025-12-08 05:16:26 | -29.57% |
| DSP Large & Mid Cap Fund | 479,317 | 0.95 | 164.09 | N/A | N/A | N/A |
| Axis Small Cap Fund | 464,211 | 0.59 | 158.92 | N/A | N/A | N/A |
| Motilal Oswal ELSS Tax Saver Fund | 400,000 | 3.08 | 136.94 | 430,073 | 2025-12-15 04:04:44 | -6.99% |
| Nippon India Small Cap Fund | 396,772 | 0.2 | 135.83 | 410,584 | 2025-12-15 03:04:08 | -3.36% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 49.70 | 39.60 | 120.44 | 70.63 | -20.17 |
| Diluted EPS (Rs.) | 49.70 | 39.60 | 120.44 | 70.63 | -20.17 |
| Cash EPS (Rs.) | 81.95 | 65.64 | 141.93 | 89.33 | -1.77 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 659.93 | 540.40 | 502.57 | 385.10 | 316.70 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 659.93 | 540.40 | 502.57 | 385.10 | 316.70 |
| Revenue From Operations / Share (Rs.) | 431.07 | 389.70 | 517.49 | 359.91 | 241.28 |
| PBDIT / Share (Rs.) | 110.52 | 92.33 | 194.59 | 120.99 | 72.55 |
| PBIT / Share (Rs.) | 78.25 | 66.29 | 173.10 | 102.28 | 54.16 |
| PBT / Share (Rs.) | 64.87 | 54.17 | 162.47 | 95.15 | 43.91 |
| Net Profit / Share (Rs.) | 49.68 | 39.60 | 120.44 | 70.63 | -20.17 |
| NP After MI And SOA / Share (Rs.) | 49.69 | 39.60 | 120.97 | 71.66 | -19.91 |
| PBDIT Margin (%) | 25.63 | 23.69 | 37.60 | 33.61 | 30.06 |
| PBIT Margin (%) | 18.15 | 17.01 | 33.45 | 28.41 | 22.44 |
| PBT Margin (%) | 15.04 | 13.90 | 31.39 | 26.43 | 18.19 |
| Net Profit Margin (%) | 11.52 | 10.16 | 23.27 | 19.62 | -8.35 |
| NP After MI And SOA Margin (%) | 11.52 | 10.16 | 23.37 | 19.91 | -8.25 |
| Return on Networth / Equity (%) | 7.52 | 7.32 | 24.06 | 18.49 | -6.26 |
| Return on Capital Employeed (%) | 10.63 | 10.81 | 31.52 | 22.60 | 14.23 |
| Return On Assets (%) | 5.14 | 4.71 | 15.87 | 11.44 | -3.66 |
| Long Term Debt / Equity (X) | 0.05 | 0.06 | 0.03 | 0.10 | 0.11 |
| Total Debt / Equity (X) | 0.27 | 0.33 | 0.26 | 0.36 | 0.40 |
| Asset Turnover Ratio (%) | 0.47 | 0.48 | 0.74 | 0.59 | 0.42 |
| Current Ratio (X) | 1.70 | 1.36 | 1.50 | 1.28 | 1.08 |
| Quick Ratio (X) | 0.97 | 0.73 | 0.86 | 0.78 | 0.59 |
| Inventory Turnover Ratio (X) | 2.79 | 1.52 | 2.61 | 2.28 | 1.73 |
| Dividend Payout Ratio (NP) (%) | 6.03 | 5.05 | 3.30 | 2.79 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 3.65 | 3.04 | 2.80 | 2.21 | 0.00 |
| Earning Retention Ratio (%) | 93.97 | 94.95 | 96.70 | 97.21 | 0.00 |
| Cash Earning Retention Ratio (%) | 96.35 | 96.96 | 97.20 | 97.79 | 0.00 |
| Interest Coverage Ratio (X) | 8.26 | 7.62 | 18.30 | 16.95 | 7.08 |
| Interest Coverage Ratio (Post Tax) (X) | 4.71 | 4.27 | 12.33 | 10.90 | -0.96 |
| Enterprise Value (Cr.) | 46006.81 | 35822.28 | 34443.07 | 31565.58 | 7693.95 |
| EV / Net Operating Revenue (X) | 9.71 | 8.37 | 6.06 | 7.98 | 2.90 |
| EV / EBITDA (X) | 37.88 | 35.32 | 16.11 | 23.75 | 9.65 |
| MarketCap / Net Operating Revenue (X) | 9.33 | 7.95 | 5.83 | 7.64 | 2.38 |
| Retention Ratios (%) | 93.96 | 94.94 | 96.69 | 97.20 | 0.00 |
| Price / BV (X) | 6.09 | 5.73 | 6.00 | 7.10 | 1.81 |
| Price / Net Operating Revenue (X) | 9.33 | 7.95 | 5.83 | 7.64 | 2.38 |
| EarningsYield | 0.01 | 0.01 | 0.04 | 0.02 | -0.03 |
After reviewing the key financial ratios for Gujarat Fluorochemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 49.70. This value is within the healthy range. It has increased from 39.60 (Mar 24) to 49.70, marking an increase of 10.10.
- For Diluted EPS (Rs.), as of Mar 25, the value is 49.70. This value is within the healthy range. It has increased from 39.60 (Mar 24) to 49.70, marking an increase of 10.10.
- For Cash EPS (Rs.), as of Mar 25, the value is 81.95. This value is within the healthy range. It has increased from 65.64 (Mar 24) to 81.95, marking an increase of 16.31.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 659.93. It has increased from 540.40 (Mar 24) to 659.93, marking an increase of 119.53.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 659.93. It has increased from 540.40 (Mar 24) to 659.93, marking an increase of 119.53.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 431.07. It has increased from 389.70 (Mar 24) to 431.07, marking an increase of 41.37.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 110.52. This value is within the healthy range. It has increased from 92.33 (Mar 24) to 110.52, marking an increase of 18.19.
- For PBIT / Share (Rs.), as of Mar 25, the value is 78.25. This value is within the healthy range. It has increased from 66.29 (Mar 24) to 78.25, marking an increase of 11.96.
- For PBT / Share (Rs.), as of Mar 25, the value is 64.87. This value is within the healthy range. It has increased from 54.17 (Mar 24) to 64.87, marking an increase of 10.70.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 49.68. This value is within the healthy range. It has increased from 39.60 (Mar 24) to 49.68, marking an increase of 10.08.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 49.69. This value is within the healthy range. It has increased from 39.60 (Mar 24) to 49.69, marking an increase of 10.09.
- For PBDIT Margin (%), as of Mar 25, the value is 25.63. This value is within the healthy range. It has increased from 23.69 (Mar 24) to 25.63, marking an increase of 1.94.
- For PBIT Margin (%), as of Mar 25, the value is 18.15. This value is within the healthy range. It has increased from 17.01 (Mar 24) to 18.15, marking an increase of 1.14.
- For PBT Margin (%), as of Mar 25, the value is 15.04. This value is within the healthy range. It has increased from 13.90 (Mar 24) to 15.04, marking an increase of 1.14.
- For Net Profit Margin (%), as of Mar 25, the value is 11.52. This value exceeds the healthy maximum of 10. It has increased from 10.16 (Mar 24) to 11.52, marking an increase of 1.36.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 11.52. This value is within the healthy range. It has increased from 10.16 (Mar 24) to 11.52, marking an increase of 1.36.
- For Return on Networth / Equity (%), as of Mar 25, the value is 7.52. This value is below the healthy minimum of 15. It has increased from 7.32 (Mar 24) to 7.52, marking an increase of 0.20.
- For Return on Capital Employeed (%), as of Mar 25, the value is 10.63. This value is within the healthy range. It has decreased from 10.81 (Mar 24) to 10.63, marking a decrease of 0.18.
- For Return On Assets (%), as of Mar 25, the value is 5.14. This value is within the healthy range. It has increased from 4.71 (Mar 24) to 5.14, marking an increase of 0.43.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. It has decreased from 0.06 (Mar 24) to 0.05, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.27. This value is within the healthy range. It has decreased from 0.33 (Mar 24) to 0.27, marking a decrease of 0.06.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.47. It has decreased from 0.48 (Mar 24) to 0.47, marking a decrease of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 1.70. This value is within the healthy range. It has increased from 1.36 (Mar 24) to 1.70, marking an increase of 0.34.
- For Quick Ratio (X), as of Mar 25, the value is 0.97. This value is below the healthy minimum of 1. It has increased from 0.73 (Mar 24) to 0.97, marking an increase of 0.24.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.79. This value is below the healthy minimum of 4. It has increased from 1.52 (Mar 24) to 2.79, marking an increase of 1.27.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 6.03. This value is below the healthy minimum of 20. It has increased from 5.05 (Mar 24) to 6.03, marking an increase of 0.98.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 3.65. This value is below the healthy minimum of 20. It has increased from 3.04 (Mar 24) to 3.65, marking an increase of 0.61.
- For Earning Retention Ratio (%), as of Mar 25, the value is 93.97. This value exceeds the healthy maximum of 70. It has decreased from 94.95 (Mar 24) to 93.97, marking a decrease of 0.98.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 96.35. This value exceeds the healthy maximum of 70. It has decreased from 96.96 (Mar 24) to 96.35, marking a decrease of 0.61.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 8.26. This value is within the healthy range. It has increased from 7.62 (Mar 24) to 8.26, marking an increase of 0.64.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.71. This value is within the healthy range. It has increased from 4.27 (Mar 24) to 4.71, marking an increase of 0.44.
- For Enterprise Value (Cr.), as of Mar 25, the value is 46,006.81. It has increased from 35,822.28 (Mar 24) to 46,006.81, marking an increase of 10,184.53.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 9.71. This value exceeds the healthy maximum of 3. It has increased from 8.37 (Mar 24) to 9.71, marking an increase of 1.34.
- For EV / EBITDA (X), as of Mar 25, the value is 37.88. This value exceeds the healthy maximum of 15. It has increased from 35.32 (Mar 24) to 37.88, marking an increase of 2.56.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 9.33. This value exceeds the healthy maximum of 3. It has increased from 7.95 (Mar 24) to 9.33, marking an increase of 1.38.
- For Retention Ratios (%), as of Mar 25, the value is 93.96. This value exceeds the healthy maximum of 70. It has decreased from 94.94 (Mar 24) to 93.96, marking a decrease of 0.98.
- For Price / BV (X), as of Mar 25, the value is 6.09. This value exceeds the healthy maximum of 3. It has increased from 5.73 (Mar 24) to 6.09, marking an increase of 0.36.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 9.33. This value exceeds the healthy maximum of 3. It has increased from 7.95 (Mar 24) to 9.33, marking an increase of 1.38.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Gujarat Fluorochemicals Ltd:
- Net Profit Margin: 11.52%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 10.63% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.52% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.71
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.97
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 58.5 (Industry average Stock P/E: 74.82)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.27
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 11.52%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | Survey No 16/3, 26 and 27, Village Ranjitnagar, Panchmahal District Gujarat 389380 | bvdesai@gfl.co.in http://www.gfl.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Devendra Kumar Jain | Chairman & Non Independent Director |
| Mr. Vivek Kumar Jain | Managing Director |
| Dr. Bir Kapoor | Deputy Managing Director |
| Mr. Sanath Kumar Muppirala | Whole Time Director |
| Mr. Niraj Agnihotri | Whole Time Director |
| Mr. Shanti Prashad Jain | Independent Director |
| Mr. Shailendra Swarup | Independent Director |
| Mr. Om Prakash Lohia | Independent Director |
| Mr. Chandra Prakash Jain | Independent Director |
| Ms. Vanita Bhargava | Independent Director |
FAQ
What is the intrinsic value of Gujarat Fluorochemicals Ltd?
Gujarat Fluorochemicals Ltd's intrinsic value (as of 19 December 2025) is 2690.80 which is 25.50% lower the current market price of 3,612.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 39,755 Cr. market cap, FY2025-2026 high/low of 4,450/3,100, reserves of ₹7,606 Cr, and liabilities of 10,618 Cr.
What is the Market Cap of Gujarat Fluorochemicals Ltd?
The Market Cap of Gujarat Fluorochemicals Ltd is 39,755 Cr..
What is the current Stock Price of Gujarat Fluorochemicals Ltd as on 19 December 2025?
The current stock price of Gujarat Fluorochemicals Ltd as on 19 December 2025 is 3,612.
What is the High / Low of Gujarat Fluorochemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Gujarat Fluorochemicals Ltd stocks is 4,450/3,100.
What is the Stock P/E of Gujarat Fluorochemicals Ltd?
The Stock P/E of Gujarat Fluorochemicals Ltd is 58.5.
What is the Book Value of Gujarat Fluorochemicals Ltd?
The Book Value of Gujarat Fluorochemicals Ltd is 693.
What is the Dividend Yield of Gujarat Fluorochemicals Ltd?
The Dividend Yield of Gujarat Fluorochemicals Ltd is 0.08 %.
What is the ROCE of Gujarat Fluorochemicals Ltd?
The ROCE of Gujarat Fluorochemicals Ltd is 9.89 %.
What is the ROE of Gujarat Fluorochemicals Ltd?
The ROE of Gujarat Fluorochemicals Ltd is 8.29 %.
What is the Face Value of Gujarat Fluorochemicals Ltd?
The Face Value of Gujarat Fluorochemicals Ltd is 1.00.